Avacta Group (AVCT)
15/11/2017 - 08:14 StockMarketWire
Avacta, the developer of Affimer biotherapeutics and reagents, has announced that Covance will be presenting Affimer d...
15/11/2017 - 07:00 RNS
RNS Number: 4911W Avacta Group PLC 15 November 2017 15 November 2017 Avacta Group plc ("Avacta", "the Group" or "the Company") Covance to Present Affimer Data at European Conference Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and reagents, is pleased to announce that Covance will be presenting Affimer data from a j...
14/11/2017 - 15:27 RNS
RNS Number: 4901W Avacta Group PLC 14 November 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Avacta Group ...
13/11/2017 - 07:52 StockMarketWire
Avacta Group chief scientific officer, Dr Amrik Basran, will be presenting an update on the Affimer therapeutics program...
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment